Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Semin Immunol. 2020 Nov 30;52:101425. doi: 10.1016/j.smim.2020.101425

Figure 1. Nanobodies and their targets in relation to the tumor (microenvironment).

Figure 1

A. Schematic representation of a conventional human Ig, camelid HCab, and a nanobody. B. Schematic overview of the tumor-associated targets for which nanobodies have currently been established. Important targets are immune cell markers, tumor cell (membrane) proteins, receptor ligands, and proteins associated with the tumor microenvironment.